Indoco’s revenues grow by 22.4 per cent in Q4
EBIDTA for the quarter stood at Rs 246.0 million Indoco Remedies announced its un-audited results for the fourth quarter of the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Ranbaxy gets approval for Absorica
Product to be launched as Absorica in the US market in Q4 of 2012 Ranbaxy Laboratories Inc (RLI), a wholly-owned subsidiary of…
IPA elects new office bearers
Indian Pharmaceutical Association (IPA), a premier professional association of pharmacists in India, with a member base of over…
Schreiner MediPharm develops functional label for safe use of auto injectors
Schreiner MediPharm has come up with a suite of additional innovative functions for its new auto injector labels that enhance ease…
Aurobindo Pharma receives approvals
Aurobindo Pharma has announced that its tentatively approved ANDAs for Nevirapine Tablets 200 mg (ANDA 077521) and Nevirapine Oral…
Quintiles releases New Health Report 2012
Biopharmaceutical services company Quintiles has commissioned New Health Report 2012. Now in its third year, The New Health Report…
Present pharma pricing policy will hurt both patients and industry in the long run: Experts
Suitable alternative required to balance the need for low drug prices, sustained innovation and access to affordable healthcare…
IHP, PFCD concludes expert panel discussion on NCDs
India Health Progress (IHP) and Partnership to Fight Chronic Disease (PFCD) has hosted a panel discussion in Chennai on…
Piramal Healthcare to present phase I data for oral anticancer molecule at ASCO
Piramal Healthcare announced that phase I clinical trial data for its investigational new drug candidate P1446A-05 will be…
Venus Remedies bags patent grant from SA
Venus Remedies has received its first patent for a novel antibiotic combination of carbapenem and aminoglycoside. Pioneering into…
Health ministers to debate binding convention on R&D
MSF urges the ministers at the 65th World Health Assembly to seize this unique opportunity The world’s health ministers, gathering…
DBT calls for proposals on low cost health care technologies, products
Diagnostics for infectious disease and allergy, biomedical devices and vaccines are key focus areas; submissions close on June 30,…
US FDA gives approval for generic version of Plavix
The US FDA has approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate). The companies which have…
Ind-Swift with Wockhardt UK launches atorvastatin tabs in UK
Ind-Swift Laboratories has launched generic formulations of atorvastatin in the UK in collaboration with Wockhardt UK on the first…
Aurobindo Pharma receives US FDA approval
Aurobindo Pharma has received final approval from the US FDA to manufacture and market Lamivudine and Zidovudine tablets USP…
Piramal Healthcare to acquire US-based DRG for Rs 3,400 cr
Piramal Healthcare has decided to enter the healthcare information segment by acquiring 100 per cent stake in US-based firm…
Ella Foundation receives $100 K grant from Bill & Melinda Gates Foundation
Ella Foundation has won $ 100K Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates…
Bristol-Myers Squibb Foundation to expand ‘Together on Diabetes’ initiative in India and…
The Bristol-Myers Squibb Foundation (BMSF) has announced the expansion of its Together on Diabetes initiative to India and China,…
Rockwell Automation introduces Assurance Integrated Support agreements
Rockwell Automation has announced the availability of Assurance Integrated Support agreements in response to customer requests for…
Glenmark Generics bags US FDA approval
Glenmark Generics Inc, USA, the US subsidiary of Glenmark Generic, has been granted tentative approval by US FDA for zolmitriptan…